Short Bio

Dr. Geoffrey Ginsburg is Professor of Medicine and Director of the Center for Genomic Medicine. After receiving his MD and PhD in biophysics from Boston University in 1984, he joined the staff of Beth Israel Hospital and Harvard Medical School after completing an internship and residency there in 1987. In 1987, Dr. Ginsburg was awarded the Bugher Foundation Fellowship with the American Heart Association, with which he completed postdoctoral training in molecular biology and cardiovascular medicine at both Children’s and Beth Israel hospitals respectively. At Beth Israel Hospital he was Director of Preventive Cardiology and at Children’s Hospital he led a laboratory in applied genetics in cardiovascular disease.</p><p>  Dr. Ginsburg joined Millennium Pharmaceuticals, Inc., in 1997 as program director for cardiovascular disease and led discovery programs in atherosclerosis and congestive heart failure.  Subsequently, he directed efforts in high throughput target discovery for early stage gene-based drug development programs for several strategic partnerships at Millennium.  In 2000 he was appointed vice president of molecular and personalized medicine where he was responsible for the Millennium’s personalized medicine initiatives to develop biomarkers for disease and pharmacogenomic strategies for therapeutics and their implementation in drug development process.  His responsibilities also included translational research efforts and strategic academic alliances required to integrate genomics into the practice of medicine.  Dr. Ginsburg is a founder of the Personalized Medicine Coalition, a non-profit organization based in Washington DC.  He is the recipient of several research awards, holds positions on editorial boards of journals for genomics and pharmacogenomics, and was recently part of an international expert panel for Genome Canada and Genoma Espana.

Research Interests

Genomic medicine, cardiomics.

Related Links

For more information, please click here http://www.genome.duke.edu/people/faculty/ginsburg.